Racotumomab–alum vaccine for the treatment of non-small-cell lung cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Racotumomab–alum vaccine for the treatment of non-small-cell lung cancer
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 14, Issue 1, Pages 9-20
Publisher
Informa UK Limited
Online
2014-11-25
DOI
10.1586/14760584.2015.984691
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
- (2014) S. Alfonso et al. CLINICAL CANCER RESEARCH
- Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody
- (2014) A. M. Hernandez et al. JOURNAL OF IMMUNOLOGY
- Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties
- (2013) Nely Rodríguez-Zhurbenko et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells
- (2013) Ana Victoria Casadesús et al. GLYCOCONJUGATE JOURNAL
- Adjuvant MAGE-A3 Immunotherapy in Resected Non–Small-Cell Lung Cancer: Phase II Randomized Study Results
- (2013) Johan Vansteenkiste et al. JOURNAL OF CLINICAL ONCOLOGY
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
- (2013) Charles Butts et al. LANCET ONCOLOGY
- Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody
- (2012) Nobuyoshi Hayashi et al. CANCER SCIENCE
- Lung Cancer: A Classic Example of Tumor Escape and Progression While Providing Opportunities for Immunological Intervention
- (2012) Martin R. Jadus et al. Clinical & Developmental Immunology
- Carbohydrate to carbohydrate interaction in development process and cancer progression
- (2012) Kazuko Handa et al. GLYCOCONJUGATE JOURNAL
- Physicochemical and biological characterization of 1E10 Anti-Idiotype vaccine
- (2011) Yoan J Machado et al. BMC BIOTECHNOLOGY
- Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer
- (2011) Alejandra M. Scursoni et al. Clinical & Developmental Immunology
- Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy
- (2011) L. G. Durrant et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Prognostic Immune Markers in Non–Small Cell Lung Cancer
- (2011) Kei Suzuki et al. CLINICAL CANCER RESEARCH
- Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial
- (2011) Charles Butts et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Anti-NeuGcGM3 Antibodies, Actively Elicited by Idiotypic Vaccination in Nonsmall Cell Lung Cancer Patients, Induce Tumor Cell Death by an Oncosis-Like Mechanism
- (2011) A. M. Hernandez et al. JOURNAL OF IMMUNOLOGY
- Immunotherapy for Non-small Cell Lung Cancer: Novel Approaches to Improve Patient Outcome
- (2011) Frances A. Shepherd et al. Journal of Thoracic Oncology
- Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial
- (2011) Elisabeth Quoix et al. LANCET ONCOLOGY
- The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer
- (2010) Roy M. Bremnes et al. Journal of Thoracic Oncology
- Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model
- (2009) D. Fuentes et al. BREAST CANCER RESEARCH AND TREATMENT
- Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines
- (2009) Mariano R Gabri et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Anti-ganglioside anti-idiotypic monoclonal antibody-based cancer vaccine induces apoptosis and antiangiogenic effect in a metastatic lung carcinoma
- (2008) Y. Diaz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Effective Inhibition of the Epidermal Growth Factor/Epidermal Growth Factor Receptor Binding by Anti-Epidermal Growth Factor Antibodies Is Related to Better Survival in Advanced Non-Small-Cell Lung Cancer Patients Treated with the Epidermal Growth Factor Cancer Vaccine
- (2008) B. Garcia et al. CLINICAL CANCER RESEARCH
- T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55
- (2008) G.J. Ullenhag et al. CLINICAL IMMUNOLOGY
- Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease
- (2008) V. Padler-Karavani et al. GLYCOBIOLOGY
- Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains
- (2007) Adriane Regina Todeschini et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More